Patents by Inventor Mathew Yanik

Mathew Yanik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11472831
    Abstract: The present application relates to isotopically labeled compounds of Formula I and methods of preparation and use thereof.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: October 18, 2022
    Assignee: Intercept Pharmaceuticals, Inc.
    Inventors: Gabriel Galvin, Kevin Schaab, Mathew Yanik
  • Publication number: 20220127302
    Abstract: The present disclosure relates to methods and novel intermediates useful in the preparation of a compound of formula I or pharmaceutically acceptable salt, hydrate, solvate or amino acid, sulfate or glucuronide conjugate, or prodrug thereof.
    Type: Application
    Filed: June 8, 2021
    Publication date: April 28, 2022
    Inventors: Roberto PELLICCIARI, Antimo GIOIELLO, Gabriel GALVIN, Ronald D. LEWIS, II, Mathew YANIK, Myoung Goo KIM, Frederik Ronald LEUSINK, Bartjan KONING, Thomas HENSEL
  • Patent number: 11066437
    Abstract: The present disclosure relates to methods and novel intermediates useful in the preparation of a compound of formula I or pharmaceutically acceptable salt, hydrate, solvate or amino acid, sulfate or glucuronide conjugate, or prodrug thereof, comprising the step of reacting a compound of formula I-4 with a halogenating reagent to provide a compound of formula I-5a
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: July 20, 2021
    Assignee: Intercept Pharmaceuticals, Inc.
    Inventors: Roberto Pellicciari, Antimo Gioiello, Gabriel Galvin, Ronald D. Lewis, II, Mathew Yanik, Myoung Goo Kim, Frederik Ronald Leusink, Bartjan Koning, Thomas Hensel
  • Publication number: 20200165290
    Abstract: The present application relates to isotopically labeled compounds of Formula I and methods of preparation and use thereof.
    Type: Application
    Filed: July 23, 2018
    Publication date: May 28, 2020
    Inventors: Gabriel GALVIN, Kevin SCHAAB, Mathew YANIK
  • Publication number: 20180371009
    Abstract: The present disclosure relates to methods and novel intermediates useful in the preparation of a compound of formula I or pharmaceutically acceptable salt, hydrate, solvate or amino acid, sulfate or glucuronide conjugate, or prodrug thereof.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 27, 2018
    Inventors: Roberto Pellicciari, Antimo Gioiello, Gabriel Galvin, Ronald D Lewis, Mathew Yanik, Myoung Goo Kim, Fred Leusink, Bartjan Koning, Thomas Hensel